The American Heart Association has expanded its professional education portfolio to help clinicians put the first-ever cardiovascular-kidney-metabolic (CKM) syndrome guideline into practice, offering resources that range from 15-minute micro-learnings to in-depth courses and point-of-care tools. The announcement matters because cardiovascular, kidney and metabolic conditions such as Type 2 diabetes and obesity frequently overlap, and the Association frames coordinated care as increasingly essential rather than optional.
The stakes are structural as much as clinical. Clinicians trained to treat one condition at a time must now assess how heart, kidney and metabolic health influence one another, and the new materials are built to fit different learning styles and demanding schedules. Continuing education credit offerings vary across the formats, giving physicians, nurses, pharmacists and other team members flexibility in how they build competency.
Much of the content is housed on the Association's CKM Health for Professionals site, which is designed to help care teams apply the latest CKM science confidently. The lightest-touch option, Micro-Learnings (15 minutes or less), uses short videos and activities covering practical skills such as measuring waist circumference, highlights from the 2026 CKM guideline, the PREVENT equations, weight-management conversations and bridging gaps in CKM care.
For deeper engagement, the portfolio includes 30-minute podcast episodes on implementing evidence-based care, one of which offers CE credit on therapeutic applications for metabolic dysfunction-associated steatotic liver disease, a condition rising alongside metabolic risk factors. Longer on-demand videos include the recorded virtual summit CKM Syndrome Guideline Unpacked: A Unified Approach for Interdisciplinary Prevention & Care, which features insights from the guideline writing committee.
The practical implications extend to risk calculation and workflow. A QuickStart guide supports use of the American Heart Association Predicting Risk of cardiovascular disease EVENTsTM (PREVENT) Online Calculator, which estimates 10- and 30-year cardiovascular disease risk by integrating cardiovascular, kidney and metabolic measures. Downloadable toolkits, including a step-by-step clinical QuickStart guide covering screening, risk stratification, staging and management, are intended to embed the guidance in day-to-day practice rather than leave it in the classroom.
Several of the offerings stem from the Association's Cardiovascular-Kidney-Metabolic Health Initiative, supported by founding sponsors Novo Nordisk and Boehringer Ingelheim, supporting sponsors Novartis Pharmaceuticals Corporation and Bayer, and champion sponsor DaVita. That backing signals industry alignment behind earlier diagnosis and better management of overlapping conditions, an effort the Association says is aimed at improving how clinicians and patients manage cardiovascular risk. The organization maintains broader resources at heart.org and stroke.org, and the original release is available via www.newmediawire.com.
